Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Valeant wins over docs with trips, fees
Medical Marketing and Media
Thursday, November 13, 2014 - 4:06pm
tags:
Valeant Pharmaceuticals, physicians
Sanofi execs prep their pitch on a post-Viehbacher R&D strategy
Fierce Biotech
Thursday, November 13, 2014 - 12:59pm
tags:
Sanofi, R&D
Servier Joins Hands With Intarcia Therapeutics To Develop Implantable Diabetic Pump
Bidness Etc.
Thursday, November 13, 2014 - 12:56pm
tags:
Servier, Intarcia, diabetes, devices
Pfizer, Gates Foundation, expand contraceptive access in poor nations
Yahoo/Reuters
Thursday, November 13, 2014 - 12:29pm
tags:
Pfizer, Bill Gates, contraceptives
Mallinckrodt ADHD Drug Hits FDA Trouble; Stock Drops
Investors.com
Thursday, November 13, 2014 - 12:04pm
tags:
Mallinckrodt, ADHD, FDA, methylphenidate ER, Concerta
Humira is in the crosshairs as Amgen gets its first Phase III biosimilars win
Reuters
Thursday, November 13, 2014 - 11:29am
tags:
Humira, Amgen, biosimilars
FDA clears label expansion for Janssen antipsychotic
Seeking Alpha
Thursday, November 13, 2014 - 11:04am
tags:
FDA, JNJ, Janssen, antipsychotics
Under siege by Biogen's new long-acting Eloctate, Baxter's Advate stands its ground
Fierce Pharma Marketing
Thursday, November 13, 2014 - 11:02am
tags:
Biogen Idec, Elocate, Baxter International, Advate
A Day Of Reckoning Approaches For Merck And Its Critics
Forbes
Thursday, November 13, 2014 - 10:29am
tags:
Merck, Zetia, Vytorin
Arena Pharmaceuticals (ARNA) Shares March Higher, Can It Continue?
Yahoo/Zacks.com
Thursday, November 13, 2014 - 10:27am
tags:
Arena Pharmaceuticals
AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods
Yahoo
Thursday, November 13, 2014 - 9:38am
tags:
AstraZeneca, Isis Pharmaceuticals, drug delivery, oligonucleotide
4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic
24/7 Wall St
Thursday, November 13, 2014 - 9:34am
tags:
hepatitis C, AbbVie, Achillion, Gilead Sciences, Merck
The Rationale For Using Brincidofovir (BCV) In Ebola Patients
Forbes
Thursday, November 13, 2014 - 8:22am
tags:
Brincidofovir, ebola virus, Chimerix
AstraZeneca developing reversal agent for heart drug Brilinta
Yahoo/Reuters
Thursday, November 13, 2014 - 8:13am
tags:
AstraZeneca, Brilinta
U.S. gene study raises hope for Merck cholesterol drug Zetia
Yahoo/Reuters
Thursday, November 13, 2014 - 8:11am
tags:
Merck, Zetia
Obesity drug war may be about more than marketing to the overweight
Medical Marketing and Media
Wednesday, November 12, 2014 - 4:52pm
tags:
obesity, Contrave, Orexigen, Eisai
1 Biotech Beast Worth Tracking
Yahoo/Benzinga
Wednesday, November 12, 2014 - 4:37pm
tags:
Incyte, Merck, Novartis, Eli Lilly, Pfizer
Pharma Trade Group Head Causes a Stir With a Remark About Patents
WSJ Pharmalot
Wednesday, November 12, 2014 - 4:32pm
tags:
International Federation of Pharmaceutical Manufacturers Association, patents
Missing the old pharma swag? Take a trip down memory lane
Fierce Pharma Marketing
Wednesday, November 12, 2014 - 1:22pm
tags:
drug reps, pharma industry
Indian drugmakers see U.S. sales hit by delay in new approvals
Reuters
Wednesday, November 12, 2014 - 11:48am
tags:
India, FDA, drug approvals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.